Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience

EMIS+ Verified independent store

→

Clinical Summary: AMILI Probiotics Formulation 4 is a high-potency synbiotic containing 15 billion CFU across 5 clinically studied strains, formulated for digestive health optimisa tion, microbiota rebalancing, and gut resilience. The formulation is powered by Limosilactobacillus reuteri, a strain with documented anti-inflammatory and antimicrobial properties, combined with Lactiplantibacillus plantarum, Bifidobacterium breve, Lacticaseibacillus rhamnosus, and Streptococcus thermophilus with prebiotic FOS in delayed-release capsules. Indicated for adults with functional gastrointestinal symptoms, post-antibiotic dysbiosis, or microbiome test results indicating reduced digestive health biomarkers. Product Overview AMILI Probiotics Formulation 4, designated the Digestive Health formulation, delivers the highest colony-forming unit count in the AMILI precision probiotics range at 15 billion CFU per capsule. This formulation addresses the foundational layer of gut health — microbial diversity, mucosal barrier integrity, and digestive function — through a five-strain consortium anchored by Limosilactobacillus reuteri. L. reuteri is among the most extensively studied probiotic organisms in gastroenterology, with over 170 published clinical trials documenting its effects on gastrointestinal motility, pathogen inhibition via reuterin production, and intestinal epithelial barrier reinforcement. Developed by AMILI Pte Ltd using strain selection informed by Asia's largest multi-ethnic gut microbiome reference database (AMILI BioCloud), Formulation 4 is calibrated for the digestive health challenges prevalent in Southeast Asian populations, including functional dyspepsia, irregular bowel habits, and antibiotic-associated microbiome disruption. The elevated 15 billion CFU dosage reflects clinical trial protocols for digestive health endpoints, where higher organism counts are associated with more consistent therapeutic responses. Delayed-release vegetarian capsules ensure organism viability through gastric acid transit, delivering viable bacteria to the colonic environment where they can establish colonisation and exert localised anti-inflammatory effects. Specifications Manufacturer AMILI Pte Ltd, Singapore Product Type High-Potency Synbiotic Supplement (Probiotic + Prebiotic) Total CFU Count 15 Billion CFU per capsule (at time of manufacture) Lead Strain Limosilactobacillus reuteri (formerly Lactobacillus reuteri) Probiotic Strains (5 strains) Limosilactobacillus reuteri, Lactiplantibacillus plantarum, Bifidobacterium breve, Lacticaseibacillus rhamnosus, Streptococcus salivarius subsp. thermophilus Prebiotic Component Fructo-oligosaccharide (FOS) Powder 95% Additional Ingredients Citrus Aurantium Extract (Orange Peel), Guar Gum Capsule Type Delayed-Release Vegetarian Capsule (acid-resistant) Serving Size 1 capsule daily Capsules Per Pack 30 capsules (30-day supply) Storage Store below 25°C in a cool, dry place. Refrigeration recommended after opening. Allergen Information Free from gluten, dairy, soy, nuts, and artificial preservatives Regulatory Compliance Manufactured under ISO 22000 food safety management standards; GMP-certified production facility; compliant with Singapore Food Agency (SFA) regulations; HSA Singapore health supplement notification Research Foundation Developed from Asia's largest multi-ethnic microbiome reference database (AMILI BioCloud) Packaging Sealed bottle with desiccant, tamper-evident closure Clinical Indications and Key Applications Functional gastrointestinal symptom management including bloating, irregular bowel habits, abdominal discomfort, and functional dyspepsia in adults Post-antibiotic microbiome restoration and recolonisation following broad-spectrum antimicrobial therapy disrupting commensal gut bacteria Gut barrier integrity reinforcement for individuals with increased intestinal permeability markers or chronic low-grade gastrointestinal inflammation Traveller's digestive health support for individuals exposed to novel microbial environments, unfamiliar dietary patterns, and water source changes Recommended formulation for individuals with AMILI Enhanced Gut Microbiome Test results indicating reduced microbial diversity, depleted Lactobacillus populations, or elevated pathobiont abundance Adjunctive digestive support for patients undergoing dietary interventions including elimination diets, low-FODMAP protocols, or therapeutic dietary transitions Frequently Asked Questions Why does Formulation 4 contain a higher CFU count than other AMILI formulations? Formulation 4 delivers 15 billion CFU per capsule compared to 9 billion (Formulation 1) and 12 billion (Formulations 2 and 3) because clinical trial evidence for digestive health endpoints consistently demonstrates dose-dependent responses. A meta-analysis published in the American Journal of Gastroenterology analysing probiotic interventions for functional gastrointestinal disorders found that formulations delivering 10 billion CFU or higher produced statistically significant improvements in global symptom scores, while lower doses showed inconsistent effects. The elevated count in Formulation 4 also compensates for organism attrition during gastrointestinal transit, ensuring therapeutic colony counts reach the colon. What makes Limosilactobacillus reuteri the lead strain for digestive health? L. reuteri is one of the most extensively characterised probiotic organisms in gastroenterology, with unique antimicrobial properties derived from its production of reuterin (3-hydroxypropionaldehyde), a broad-spectrum antimicrobial compound active against gram-positive and gram-negative pathogens. L. reuteri has also demonstrated the ability to modulate gastrointestinal motility through enteric nervous system interactions, reduce visceral pain perception, and strengthen tight junction protein expression in the intestinal epithelium. The World Gastroenterology Organisation (WGO) Global Guidelines list L. reuteri among recommended probiotic strains for multiple gastrointestinal indications. Can Formulation 4 be used during antibiotic treatment? Probiotic supplementation during antibiotic therapy is supported by clinical evidence, with a Cochrane systematic review demonstrating that concurrent probiotic use reduces antibiotic-associated diarrhoea incidence by approximately 42%. When taking Formulation 4 alongside antibiotics, a minimum 2-hour separation between antibiotic and probiotic doses is recommended to reduce direct antimicrobial exposure to the probiotic organisms. Supplementation should continue for at least 2-4 weeks after completing the antibiotic course to support microbiome recovery. Healthcare providers in Singapore should consider individual patient factors including antibiotic class, treatment duration, and patient history when advising on concurrent probiotic use. How does this formulation compare to generic digestive health probiotics available in pharmacies? AMILI Formulation 4 differs from mass-market digestive probiotics in three key aspects: strain selection based on Asian population microbiome data rather than Western reference databases; delayed-release capsule technology ensuring colonic delivery rather than standard capsules where organisms are exposed to gastric acid; and a higher 15 billion CFU count reflecting clinical trial dosing protocols. Additionally, AMILI products are developed by a microbiome science company with proprietary metagenomic sequencing capabilities, and can be paired with the AMILI Enhanced Gut Microbiome Test for personalised baseline assessment and progress monitoring. Where can healthcare practitioners in Singapore procure AMILI Formulation 4? AMILI Probiotics Formulation 4 is distributed in Singapore through EMIS (Essential Medical International Supplies Pte Ltd). Gastroenterology clinics, integrative medicine practices, functional medicine practitioners, and wellness centres can arrange institutional procurement with volume pricing. The product is classified as a health supplement under the Health Sciences Authority (HSA) Singapore regulatory framework. EMIS provides Certificates of Analysis, batch traceability documentation, and dedicated account management for healthcare institution partners requiring regulatory compliance documentation. { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What are the benefits of Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience for digestive health?", "acceptedAnswer": { "@type": "Answer", "text": "Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience by Amili promotes gut microbiome diversity, supports digestive comfort, and strengthens the gut-immune axis. For individuals with digestive concerns such as IBS, bloating, or irregular bowel habits, targeted gut health supplementation may complement a balanced diet and lifestyle. Always consult a doctor or dietitian before starting supplements for digestive conditions." } }, { "@type": "Question", "name": "Who should take Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience?", "acceptedAnswer": { "@type": "Answer", "text": "Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience may benefit adults seeking to support digestive health, those recovering from antibiotic use, individuals with irregular bowel habits, or those with conditions affecting gut microbiome balance. It is not a substitute for medical treatment. Consult your GP or gastroenterologist — available at SGH, NUH, Mount Elizabeth, and Raffles Hospital in Singapore — for personalised advice." } }, { "@type": "Question", "name": "How should I take Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience for best results?", "acceptedAnswer": { "@type": "Answer", "text": "Follow the dosage instructions on the Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience packaging or as directed by your healthcare provider. Consistency is key — most gut health supplements take 4–8 weeks of regular use to show measurable benefits. Store as directed on the label. Do not exceed the recommended daily dose." } }, { "@type": "Question", "name": "Where can I buy Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience in Singapore?", "acceptedAnswer": { "@type": "Answer", "text": "Digestive Health Formulation 4 for Microbiota Balance and Gut Resilience is available at EMIS+ (emis.asia) with fast Singapore island-wide delivery. We carry a curated range of clinically-informed digestive health supplements. Visit emis.asia or contact our team for product recommendations." } } ] } Show more